Some long-COVID sufferers are paying thousands of dollars for COVID-19 antivirals hoping they will lessen their symptoms during reinfections. While some experts say it's time to allow more Australia access to subsidised medications, others say more research is needed. ⌘ Read more
Some long-COVID sufferers are paying thousands of dollars for COVID-19 antivirals hoping they will lessen their symptoms during reinfections. While some experts say it's time to allow more Australia access to subsidised medications, others say more research is needed. ⌘ Read more